jontoledo.bsky.social @jontoledo.bsky.social · 05/11/2025Significant milestone for the Dementia with Lewy Bodies community: new DLB trials moving to Phase 3; CervoMed aligned with the FDA on a registration path for neflamapimod. #Dementia #LewyBodyDementia #DLB #ClinicalTrials #Phase3 #Neflamapimod 000
jontoledo.bsky.social @jontoledo.bsky.social · 29/10/2025@alzassociation.bsky.social critically support research to fulfill their mission of a world without Alzheimer's through: • SEEDING new ideas • SPEEDING development of new therapies • SCALING Over $450M+ funding across 56 countries, increasing their support for early-career researchers. 000
jontoledo.bsky.social @jontoledo.bsky.social · 28/10/2025Empowering the care team makes a difference in #dementia. @Alz_Journals: InDePendent trial found that tailored care by qualified nurses provided for people living with dementia led to 74% fewer unmet needs and higher quality of life, cost-effectively #dementiacare #careteam 000
jontoledo.bsky.social @jontoledo.bsky.social · 28/10/2025Texas Proposition 14, a game-changer to fight Alzheimer’s and other dementias. #TXProp14 would fund the Dementia Prevention and Research Institute of Texas (DPRIT) with a $3 billion investment from the state's budget surplus. Vote YES #AlzheimersResearch #TexasElections #DPRIT www.alz.org/yeson14 000
jontoledo.bsky.social @jontoledo.bsky.social · 13/09/2025Representing #LBDA and @houstonmethodist.bsky.social at the #HAPS Engage.Educate.Empower. Symposium 000
jontoledo.bsky.social @jontoledo.bsky.social · 08/08/2025Proud to be designated an LBDA Research Center of Excellence. This placard represents our commitment to patients and families we serve, and our dedication to advancing a cure. A huge thank you to our dedicated team and the entire LBD community. #LewyBodyDementia #DementiaResearch #LBDA #EndLBD 140
Reposted by @jontoledo.bsky.socialJAMA @jama.com · 17/03/2025When they become eligible for Medicare, beneficiaries must choose to enroll in Medicare Advantage (MA) or traditional Medicare. This Viewpoint discusses the differences between MA and traditional Medicare. ja.ma/3FzVLc0 0218
jontoledo.bsky.social @jontoledo.bsky.social · 13/03/2025Exciting work form Borghammer's lab describing sympathetic and parasympathetic involvement and brain vs body first progression in #LBD #PD #DLB further read in bit.ly/41N13Z2 022
jontoledo.bsky.social @jontoledo.bsky.social · 31/01/2025SHIMMER COG1201 #CT1812 showed in mid-moderate #DLB phase 2 exploratory positive results in NPI caregiver burden, underpowered results favoring cognitive CDR, ADL, MDS-UPDRS III for CT1812 010
jontoledo.bsky.social @jontoledo.bsky.social · 31/01/2025Well deserved rising star awards #ILBDC #DLB 030
jontoledo.bsky.social @jontoledo.bsky.social · 30/01/2025Broad expertise panel discussion in #DLB #Staging including #ATN #NSD-ISS #SynNeurGe and @LBDAssoc 010
jontoledo.bsky.social @jontoledo.bsky.social · 29/01/2025Ian McKeith was just surprised with the announcement and being awarded the first DLB lifetime award at #ILBDC #DLB 020
Reposted by @jontoledo.bsky.socialThe Lewy Body Society @lewybodysociety.bsky.social · 28/01/2025Thank you to @rorycj.bsky.social for his support on World Lewy Body Day! #dementia 021
Reposted by @jontoledo.bsky.socialThe Lewy Body Society @lewybodysociety.bsky.social · 27/01/2025Looking forward to World Lewy Body Day tomorrow! Thank you to ITN Business for sharing this on the eve of our big day. Please help us tomorrow by sharing our posts to try to get the world to understand that dementia doesn't always mean Alzheimer's. #worldlewybodyday #wlbd2025 #lewybodydementiabusiness.itn.co.ukWorld Lewy Body Dementia Day 2025: Shining a spotlight on the “unknown” dementia - ITN BusinessThis Sunday 28th January marks the first World Lewy Body Day, a new awareness day that aims to shine a light on Lewy body dementia (LBD). 064
jontoledo.bsky.social @jontoledo.bsky.social · 21/01/2025Feeling like a late and quiet Christmas day on the way to work in Houston. 020
jontoledo.bsky.social @jontoledo.bsky.social · 13/01/2025See our new paper on the impact of Lewy and Alzheimer co-pathology on cognitive and clinical changes #DLBAwareness #Alzheimers #EndDementia #CoPathologies bit.ly/3DU8WDTbit.lyCognitive decline profiles associated with lewy pathology in the context of Alzheimer’s disease neuropathologic change - Alzheimer's Research & TherapyBackground Alzheimer’s disease neuropathologic change (ADNC) and Lewy pathology (LP) often coexist in cognitively impaired individuals. These pathologies’ relative distribution and severity may modify... 041
jontoledo.bsky.social @jontoledo.bsky.social · 13/01/2025IMPACT AD; training program for professionals interested in Alzheimer's clinical trials. Overview of all clinical trials aspects, proposals reviews, career advice, and mentoring. Join the program and become an alumni. #IMPACT_AD #Alzheimers #ClinicalTrials impact-ad.org 010
